Category

Cohort News

CHO Plus Enters into Project Agreement with BARDA’s BioMaP Consortium to Develop High Productivity Cell Lines for Filovirus Monoclonal Antibody Production

//
Categories
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) — Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) for up to $10.4 million...
Read More →

New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer’s Disease Presented at the 2025 Alzheimer’s Association International Conference featuring Veravas Inc.

//
Categories
Developed by Veravas Inc., VeraBIND™ Tau Assay is the first blood-based test that measures pathologically active tau for the early detection of Alzheimer’s disease in both asymptomatic and symptomatic individuals AUSTIN, Texas, July 28, 2025 /PRNewswire/ — Veravas Inc., an...
Read More →